Pub. Date : 2011
PMID : 21894049
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy. | gemcitabine | KRAS proto-oncogene, GTPase | Homo sapiens |